H.C. Wainwright Reiterates Buy Rating on Unity Biotechnology Inc (UBX)
Tweet Send to a Friend
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating and $4.00 price target on Unity Biotechnology Inc (NASDAQ: UBX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
